GOVX

GeoVax Labs, Inc.CIK 832489 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for GOVX PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for GOVX

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Morgan Jayne	Director	4	$0	$0	2026-06-17
Lemerond Nicole	Director	4	$0	$0	2026-06-17
McKee Kelly T. Jr.	Chief Medical Officer	10	$23.8K	$0	2026-06-17
Sharkey John W.	VP, Business Development	6	$6.8K	$0	2026-06-17
Kollintzas Dean G	Director	18	$69.9K	$0	2026-06-17
Reynolds Mark	CFO	27	$349.3K	$0	2026-06-17
SPENCER JOHN N JR	Director	21	$133.5K	$0	2026-06-17
NEWMAN MARK J	Chief Scientific Officer	6	$0	$0	2026-06-17
DODD DAVID A	President, CEO	25	$571.0K	$0	2026-06-17
CHASE RANDAL D	Director	18	$113.2K	$0	2026-06-17
MCNALLY ROBERT T	President/CEO	18	$289.6K	$0	2026-06-17
Guirakhoo Farshad	Sr VP, Research & Development	5	$0	$0	2018-12-17
ROBINSON HARRIET L	Chief Scientific Officer	11	$100.0K	$0	2018-12-17
Antebi Steven S.	Director	2	$20.1K	$0	2012-01-16

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
DODD DAVID A	President, CEO	A Award deriv	2026-06-17	2026-06-22	29,300	—	$0	29,300	SEC↗
McKee Kelly T. Jr.	Chief Medical Officer	A Award deriv	2026-06-17	2026-06-22	17,600	—	$0	17,600	SEC↗
NEWMAN MARK J	Chief Scientific Officer	A Award deriv	2026-06-17	2026-06-22	17,600	—	$0	17,600	SEC↗
Reynolds Mark	CFO	A Award deriv	2026-06-17	2026-06-22	17,600	—	$0	17,600	SEC↗
Sharkey John W.	VP, Business Development	A Award deriv	2026-06-17	2026-06-22	17,600	—	$0	17,600	SEC↗
CHASE RANDAL D	Director	A Award deriv	2026-06-17	2026-06-22	6,000	—	$0	6,000	SEC↗
Kollintzas Dean G	Director	A Award deriv	2026-06-17	2026-06-22	6,000	—	$0	6,000	SEC↗
Lemerond Nicole	Director	A Award deriv	2026-06-17	2026-06-22	6,000	—	$0	6,000	SEC↗
MCNALLY ROBERT T	Director	A Award deriv	2026-06-17	2026-06-22	6,000	—	$0	6,000	SEC↗
Morgan Jayne	Director	A Award deriv	2026-06-17	2026-06-22	6,000	—	$0	6,000	SEC↗
SPENCER JOHN N JR	Director	A Award deriv	2026-06-17	2026-06-22	6,000	—	$0	6,000	SEC↗
SPENCER JOHN N JR	Director	P Buy	2025-10-17	2025-10-20	10,000	$0.55	$5.5K	21,402	SEC↗
McKee Kelly T. Jr.	Chief Medical Officer	P Buy	2025-08-07	2025-08-08	1,107	$0.67	$742	3,494	SEC↗
DODD DAVID A	President, CEO	A Award deriv	2025-06-05	2025-06-06	185,500	—	$0	185,500	SEC↗
Reynolds Mark	CFO	A Award deriv	2025-06-05	2025-06-06	70,000	—	$0	70,000	SEC↗
Sharkey John W.	VP, Business Development	A Award deriv	2025-06-05	2025-06-06	70,000	—	$0	70,000	SEC↗
McKee Kelly T. Jr.	Chief Medical Officer	A Award deriv	2025-06-05	2025-06-06	70,000	—	$0	70,000	SEC↗
NEWMAN MARK J	Chief Scientific Officer	A Award deriv	2025-06-05	2025-06-06	70,000	—	$0	70,000	SEC↗
SPENCER JOHN N JR	Director	A Award deriv	2025-06-05	2025-06-06	10,000	—	$0	10,000	SEC↗
Morgan Jayne	Director	A Award deriv	2025-06-05	2025-06-06	10,000	—	$0	10,000	SEC↗
MCNALLY ROBERT T	Director	A Award deriv	2025-06-05	2025-06-06	10,000	—	$0	10,000	SEC↗
Kollintzas Dean G	Director	A Award deriv	2025-06-05	2025-06-06	10,000	—	$0	10,000	SEC↗
CHASE RANDAL D	Director	A Award deriv	2025-06-05	2025-06-06	10,000	—	$0	10,000	SEC↗
Lemerond Nicole	Director	A Award deriv	2025-06-05	2025-06-06	10,000	—	$0	10,000	SEC↗
Sharkey John W.	VP, Business Development	P Buy	2025-04-10	2025-04-10	6,000	$0.99	$5.9K	6,191	SEC↗
SPENCER JOHN N JR	Director	P Buy	2025-04-10	2025-04-11	10,000	$0.98	$9.8K	11,402	SEC↗
DODD DAVID A	President, CEO	P Buy	2025-04-01	2025-04-01	10,000	$1.08	$10.8K	36,661	SEC↗
Reynolds Mark	CFO	P Buy	2025-03-31	2025-03-31	6,800	$1.08	$7.3K	14,013	SEC↗
SPENCER JOHN N JR	Director	A Award deriv	2024-08-12	2024-08-14	8,050	—	$0	8,050	SEC↗
Morgan Jayne	Director	A Award deriv	2024-08-12	2024-08-14	8,050	—	$0	8,050	SEC↗
MCNALLY ROBERT T	Director	A Award deriv	2024-08-12	2024-08-14	8,050	—	$0	8,050	SEC↗
Lemerond Nicole	Director	A Award deriv	2024-08-12	2024-08-14	8,050	—	$0	8,050	SEC↗
Kollintzas Dean G	Director	A Award deriv	2024-08-12	2024-08-14	8,050	—	$0	8,050	SEC↗
CHASE RANDAL D	Director	A Award deriv	2024-08-12	2024-08-14	8,050	—	$0	8,050	SEC↗
Sharkey John W.	VP, Business Development	A Award deriv	2024-08-12	2024-08-14	15,700	—	$0	15,700	SEC↗
Reynolds Mark	CFO	A Award deriv	2024-08-12	2024-08-14	15,700	—	$0	15,700	SEC↗
NEWMAN MARK J	Chief Scientific Officer	A Award deriv	2024-08-12	2024-08-14	15,700	—	$0	15,700	SEC↗
McKee Kelly T. Jr.	Chief Medical Officer	A Award deriv	2024-08-12	2024-08-14	15,700	—	$0	15,700	SEC↗
DODD DAVID A	President, CEO	A Award deriv	2024-08-12	2024-08-14	35,000	—	$0	35,000	SEC↗
DODD DAVID A	President, CEO	P Buy	2024-08-09	2024-08-12	8,000	$1.95	$15.6K	26,661	SEC↗
DODD DAVID A	President, CEO	P Buy	2024-02-22	2024-02-22	8,209	$2.27	$18.6K	18,661	SEC↗
DODD DAVID A	President, CEO	P Buy	2024-02-21	2024-02-22	520	$2.15	$1.1K	10,452	SEC↗
Reynolds Mark	CFO	P Buy	2024-02-07	2024-02-07	2,000	$2.77	$5.5K	7,213	SEC↗
McKee Kelly T. Jr.	Chief Medical Officer	P Buy	2023-12-22	2023-12-26	6,944	$0.36	$2.5K	35,782	SEC↗
McKee Kelly T. Jr.	Chief Medical Officer	P Buy	2023-09-25	2023-09-27	9,653	$0.52	$5.0K	28,838	SEC↗
DODD DAVID A	President, CEO	P Buy	2023-08-25	2023-08-28	35,087	$0.57	$20.0K	148,957	SEC↗
Reynolds Mark	CFO	P Buy	2023-08-18	2023-08-21	10,000	$0.52	$5.2K	78,184	SEC↗
Reynolds Mark	CFO	A Award deriv	2023-08-01	2023-08-14	100,000	—	$0	100,000	SEC↗
DODD DAVID A	President, CEO	A Award deriv	2023-08-01	2023-08-14	250,000	—	$0	250,000	SEC↗
NEWMAN MARK J	Chief Scientific Officer	A Award deriv	2023-08-01	2023-08-14	100,000	—	$0	100,000	SEC↗
Sharkey John W.	VP, Business Development	A Award deriv	2023-08-01	2023-08-14	100,000	—	$0	100,000	SEC↗
McKee Kelly T. Jr.	Chief Medical Officer	A Award deriv	2023-08-01	2023-08-14	15,000	—	$0	15,000	SEC↗
CHASE RANDAL D	Director	A Award deriv	2023-08-01	2023-08-14	50,000	—	$0	50,000	SEC↗
Kollintzas Dean G	Director	A Award deriv	2023-08-01	2023-08-14	50,000	—	$0	50,000	SEC↗
Lemerond Nicole	Director	A Award deriv	2023-08-01	2023-08-14	50,000	—	$0	50,000	SEC↗
MCNALLY ROBERT T	Director	A Award deriv	2023-08-01	2023-08-14	50,000	—	$0	50,000	SEC↗
Morgan Jayne	Director	A Award deriv	2023-08-01	2023-08-14	50,000	—	$0	50,000	SEC↗
SPENCER JOHN N JR	Director	A Award deriv	2023-08-01	2023-08-14	50,000	—	$0	50,000	SEC↗
DODD DAVID A	President, CEO	P Buy	2023-04-24	2023-04-25	32,000	$0.64	$20.5K	113,870	SEC↗
Reynolds Mark	CFO	P Buy	2023-04-20	2023-04-21	8,000	$0.63	$5.0K	68,184	SEC↗
CHASE RANDAL D	Director	P Buy	2022-09-21	2022-09-23	10,000	$1.10	$11.0K	36,613	SEC↗
Sharkey John W.	VP, Business Development	P Buy	2022-07-01	2022-07-05	1,000	$0.82	$820	2,860	SEC↗
McKee Kelly T. Jr.	Chief Medical Officer	P Buy	2022-06-27	2022-06-28	4,464	$1.12	$5.0K	19,185	SEC↗
CHASE RANDAL D	Director	P Buy	2022-06-21	2022-06-22	10,000	$1.21	$12.1K	26,613	SEC↗
McKee Kelly T. Jr.	Chief Medical Officer	P Buy	2022-05-05	2022-05-06	9,722	$0.72	$7.0K	14,721	SEC↗
McKee Kelly T. Jr.	Chief Medical Officer	P Buy	2022-05-04	2022-05-05	4,999	$0.71	$3.5K	4,999	SEC↗
DODD DAVID A	President, CEO	A Award deriv	2021-12-07	2021-12-08	103,000	—	$0	103,000	SEC↗
Reynolds Mark	CFO	A Award deriv	2021-12-07	2021-12-08	48,200	—	$0	48,200	SEC↗
NEWMAN MARK J	Chief Scientific Officer	A Award deriv	2021-12-07	2021-12-08	25,700	—	$0	25,700	SEC↗
CHASE RANDAL D	Director	A Award deriv	2021-12-07	2021-12-08	25,000	—	$0	25,000	SEC↗
Kollintzas Dean G	Director	A Award deriv	2021-12-07	2021-12-08	25,000	—	$0	25,000	SEC↗
MCNALLY ROBERT T	Director	A Award deriv	2021-12-07	2021-12-08	25,000	—	$0	25,000	SEC↗
SPENCER JOHN N JR	Director	A Award deriv	2021-12-07	2021-12-08	25,000	—	$0	25,000	SEC↗
SPENCER JOHN N JR	Director	A Award deriv	2021-08-11	2021-08-11	25,000	—	$0	25,000	SEC↗
CHASE RANDAL D	Director	A Award deriv	2021-08-11	2021-08-11	25,000	—	$0	25,000	SEC↗
MCNALLY ROBERT T	Director	A Award deriv	2021-08-11	2021-08-11	25,000	—	$0	25,000	SEC↗
Kollintzas Dean G	Director	A Award deriv	2021-08-11	2021-08-11	25,000	—	$0	25,000	SEC↗
NEWMAN MARK J	Chief Scientific Officer	A Award deriv	2021-08-11	2021-08-11	35,000	—	$0	35,000	SEC↗
Reynolds Mark	CFO	A Award deriv	2021-08-11	2021-08-11	128,000	—	$0	128,000	SEC↗
DODD DAVID A	President, CEO	A Award deriv	2021-08-11	2021-08-11	273,000	—	$0	273,000	SEC↗
CHASE RANDAL D	Director	P Buy deriv	2020-09-29	2020-09-29	16,613	—	$0	16,613	SEC↗
Kollintzas Dean G	Director	P Buy deriv	2020-09-29	2020-09-29	11,987	—	$0	11,987	SEC↗
SPENCER JOHN N JR	Director	P Buy deriv	2020-09-29	2020-09-29	21,024	—	$0	21,024	SEC↗
MCNALLY ROBERT T	Director	P Buy deriv	2020-09-29	2020-09-29	53,925	—	$0	53,925	SEC↗
DODD DAVID A	President, CEO	P Buy deriv	2020-09-29	2020-09-29	81,870	—	$0	81,870	SEC↗
Reynolds Mark	CFO	P Buy deriv	2020-09-29	2020-09-29	60,184	—	$0	60,184	SEC↗
CHASE RANDAL D	Director	P Buy	2020-09-29	2020-09-29	16,613	$5.00	$83.1K	16,613	SEC↗
Kollintzas Dean G	Director	P Buy	2020-09-29	2020-09-29	11,987	$5.00	$59.9K	11,987	SEC↗
SPENCER JOHN N JR	Director	P Buy	2020-09-29	2020-09-29	21,024	$5.00	$105.1K	21,024	SEC↗
MCNALLY ROBERT T	Director	P Buy	2020-09-29	2020-09-29	53,925	$5.00	$269.6K	53,925	SEC↗
DODD DAVID A	President, CEO	P Buy	2020-09-29	2020-09-29	81,870	$5.00	$409.4K	81,870	SEC↗
Reynolds Mark	CFO	P Buy	2020-09-29	2020-09-29	60,184	$5.00	$300.9K	60,184	SEC↗
DODD DAVID A	President, CEO	A Award deriv	2018-12-17	2018-12-19	785,000	—	$0	785,000	SEC↗
Guirakhoo Farshad	Chief Scientific Officer	A Award deriv	2018-12-17	2018-12-19	625,000	—	$0	625,000	SEC↗
Reynolds Mark	CFO	A Award deriv	2018-12-17	2018-12-19	750,000	—	$0	750,000	SEC↗
ROBINSON HARRIET L	CSO Emeritus	A Award deriv	2018-12-17	2018-12-19	600,000	—	$0	600,000	SEC↗
CHASE RANDAL D	Director	A Award deriv	2018-12-17	2018-12-19	320,000	—	$0	320,000	SEC↗
Kollintzas Dean G	Director	A Award deriv	2018-12-17	2018-12-19	300,000	—	$0	300,000	SEC↗
MCNALLY ROBERT T	Director	A Award deriv	2018-12-17	2018-12-19	650,000	—	$0	650,000	SEC↗
SPENCER JOHN N JR	Director	A Award deriv	2018-12-17	2018-12-19	345,000	—	$0	345,000	SEC↗
DODD DAVID A	President, CEO	A Award deriv	2018-09-01	2018-09-05	3,000,000	—	$0	3,000,000	SEC↗
Reynolds Mark	CFO	A Award deriv	2017-12-20	2017-12-22	750,000	—	$0	750,000	SEC↗
MCNALLY ROBERT T	President/CEO	A Award deriv	2017-12-20	2017-12-22	750,000	—	$0	750,000	SEC↗
Guirakhoo Farshad	Chief Scientific Officer	A Award deriv	2017-12-20	2017-12-22	500,000	—	$0	500,000	SEC↗
ROBINSON HARRIET L	CSO Emeritus	A Award deriv	2017-12-20	2017-12-22	450,000	—	$0	450,000	SEC↗
DODD DAVID A	Director	A Award deriv	2017-12-20	2017-12-22	270,000	—	$0	270,000	SEC↗
CHASE RANDAL D	Director	A Award deriv	2017-12-20	2017-12-22	200,000	—	$0	200,000	SEC↗
SPENCER JOHN N JR	Director	A Award deriv	2017-12-20	2017-12-22	240,000	—	$0	240,000	SEC↗
Kollintzas Dean G	Director	A Award deriv	2017-12-20	2017-12-22	170,000	—	$0	170,000	SEC↗
CHASE RANDAL D	Director	A Award deriv	2016-12-13	2016-12-15	106,700	—	$0	106,700	SEC↗
Reynolds Mark	CFO	A Award deriv	2016-12-13	2016-12-15	335,000	—	$0	335,000	SEC↗
Guirakhoo Farshad	Sr VP, Research & Developmen	A Award deriv	2016-12-13	2016-12-15	85,000	—	$0	85,000	SEC↗
Guirakhoo Farshad	Sr VP, Research & Developmen	A Award deriv	2016-12-13	2016-12-15	85,000	—	$0	85,000	SEC↗
MCNALLY ROBERT T	President/CEO	A Award deriv	2016-12-13	2016-12-15	462,500	—	$0	462,500	SEC↗
ROBINSON HARRIET L	Chief Scientific Officer	A Award deriv	2016-12-13	2016-12-15	262,200	—	$0	262,200	SEC↗
DODD DAVID A	Director	A Award deriv	2016-12-13	2016-12-15	202,800	—	$0	202,800	SEC↗
Kollintzas Dean G	Director	A Award deriv	2016-12-13	2016-12-15	79,275	—	$0	79,275	SEC↗
SPENCER JOHN N JR	Director	A Award deriv	2016-12-13	2016-12-15	123,500	—	$0	123,500	SEC↗
MCNALLY ROBERT T	President/CEO	A Award deriv	2015-12-11	2015-12-14	75,000	—	$0	75,000	SEC↗
ROBINSON HARRIET L	Chief Scientific Officer	A Award deriv	2015-12-11	2015-12-14	100,000	—	$0	100,000	SEC↗
Reynolds Mark	CFO	A Award deriv	2015-12-11	2015-12-14	60,000	—	$0	60,000	SEC↗
Guirakhoo Farshad	Sr VP, Research & Developmen	A Award deriv	2015-12-11	2015-12-14	60,000	—	$0	60,000	SEC↗
SPENCER JOHN N JR	Director	A Award deriv	2015-12-11	2015-12-14	30,000	—	$0	30,000	SEC↗
Kollintzas Dean G	Director	A Award deriv	2015-12-11	2015-12-14	30,000	—	$0	30,000	SEC↗
DODD DAVID A	Director	A Award deriv	2015-12-11	2015-12-14	30,000	—	$0	30,000	SEC↗
CHASE RANDAL D	Director	A Award deriv	2015-12-11	2015-12-14	30,000	—	$0	30,000	SEC↗
CHASE RANDAL D	Director	P Buy	2015-05-05	2015-05-05	200	$0.19	$38	40,000	SEC↗
CHASE RANDAL D	Director	P Buy	2015-05-05	2015-05-05	9,800	$0.19	$1.9K	39,800	SEC↗
Reynolds Mark	CFO	P Buy	2015-04-23	2015-04-23	10,000	$0.18	$1.8K	66,000	SEC↗
Reynolds Mark	CFO	P Buy	2015-04-22	2015-04-23	10,000	$0.17	$1.7K	46,000	SEC↗
Reynolds Mark	CFO	P Buy	2015-04-22	2015-04-23	10,000	$0.17	$1.7K	56,000	SEC↗
CHASE RANDAL D	Director	P Buy	2015-04-20	2015-04-20	30,000	$0.17	$5.1K	30,000	SEC↗
SPENCER JOHN N JR	Director	P Buy	2015-04-20	2015-04-20	18,000	$0.17	$3.1K	46,625	SEC↗
CHASE RANDAL D	Director	A Award deriv	2015-03-19	2015-03-23	26,400	—	$0	26,400	SEC↗
Reynolds Mark	CFO	A Award deriv	2014-12-09	2014-12-11	30,000	—	$0	30,000	SEC↗
MCNALLY ROBERT T	President/CEO	A Award deriv	2014-12-09	2014-12-11	30,000	—	$0	30,000	SEC↗
ROBINSON HARRIET L	Chief Scientific Officer	A Award deriv	2014-12-09	2014-12-11	30,000	—	$0	30,000	SEC↗
SPENCER JOHN N JR	Director	A Award deriv	2014-12-09	2014-12-11	25,000	—	$0	25,000	SEC↗
Kollintzas Dean G	Director	A Award deriv	2014-12-09	2014-12-11	25,000	—	$0	25,000	SEC↗
DODD DAVID A	Director	A Award deriv	2014-12-09	2014-12-11	25,000	—	$0	25,000	SEC↗
DODD DAVID A	Director	A Award deriv	2013-12-18	2013-12-20	25,000	—	$0	25,000	SEC↗
SPENCER JOHN N JR	Director	A Award deriv	2013-12-18	2013-12-20	25,000	—	$0	25,000	SEC↗
Kollintzas Dean G	Director	A Award deriv	2013-12-18	2013-12-20	25,000	—	$0	25,000	SEC↗
MCNALLY ROBERT T	President/CEO	A Award deriv	2013-12-18	2013-12-20	30,000	—	$0	30,000	SEC↗
ROBINSON HARRIET L	Chief Scientific Officer	A Award deriv	2013-12-18	2013-12-20	30,000	—	$0	30,000	SEC↗
Reynolds Mark	CFO	A Award deriv	2013-12-18	2013-12-20	30,000	—	$0	30,000	SEC↗
ROBINSON HARRIET L	Chief Scientific Officer	G Gift	2013-06-05	2013-06-06	27,500	—	$0	1,173,726	SEC↗
Reynolds Mark	CFO	A Award deriv	2012-12-11	2013-01-03	25,000	—	$0	25,000	SEC↗
DODD DAVID A	Director	A Award deriv	2012-12-11	2013-01-03	25,000	—	$0	25,000	SEC↗
SPENCER JOHN N JR	Director	A Award deriv	2012-12-11	2013-01-03	25,000	—	$0	25,000	SEC↗
Kollintzas Dean G	Director	A Award deriv	2012-12-11	2013-01-03	25,000	—	$0	25,000	SEC↗
MCNALLY ROBERT T	President/CEO	A Award deriv	2012-12-11	2013-01-03	30,000	—	$0	30,000	SEC↗
ROBINSON HARRIET L	Chief Scientific Officer	A Award deriv	2012-12-11	2013-01-03	25,000	—	$0	25,000	SEC↗
Reynolds Mark	CFO	P Buy deriv	2012-01-31	2012-02-01	22,500	—	$0	22,500	SEC↗
Reynolds Mark	CFO	P Buy	2012-01-31	2012-02-01	15,000	$0.67	$10.1K	36,000	SEC↗
Antebi Steven S.	Director	P Buy	2012-01-16	2012-01-17	30,000	$0.67	$20.1K	30,000	SEC↗
Reynolds Mark	CFO	P Buy deriv	2011-12-30	2012-01-04	22,500	—	$0	22,500	SEC↗
MCNALLY ROBERT T	President/CEO	P Buy deriv	2011-12-30	2012-01-04	44,775	—	$0	44,775	SEC↗
ROBINSON HARRIET L	Chief Scientific Officer	P Buy deriv	2011-12-30	2012-01-04	223,881	—	$0	223,881	SEC↗
DODD DAVID A	Director	P Buy deriv	2011-12-30	2012-01-04	168,000	—	$0	168,000	SEC↗
Kollintzas Dean G	Director	P Buy deriv	2011-12-30	2012-01-04	22,388	—	$0	22,388	SEC↗
SPENCER JOHN N JR	Director	P Buy deriv	2011-12-30	2012-01-04	22,388	—	$0	22,388	SEC↗
Reynolds Mark	CFO	A Award deriv	2011-12-30	2012-01-04	25,000	—	$0	25,000	SEC↗
MCNALLY ROBERT T	President/CEO	A Award deriv	2011-12-30	2012-01-04	30,000	—	$0	30,000	SEC↗
ROBINSON HARRIET L	Chief Scientific Officer	A Award deriv	2011-12-30	2012-01-04	25,000	—	$0	25,000	SEC↗
DODD DAVID A	Director	A Award deriv	2011-12-30	2012-01-04	25,000	—	$0	25,000	SEC↗
Kollintzas Dean G	Director	A Award deriv	2011-12-30	2012-01-04	25,000	—	$0	25,000	SEC↗
SPENCER JOHN N JR	Director	A Award deriv	2011-12-30	2012-01-04	25,000	—	$0	25,000	SEC↗
Antebi Steven S.	Director	A Award deriv	2011-12-30	2012-01-04	25,000	—	$0	25,000	SEC↗
Reynolds Mark	CFO	P Buy	2011-12-30	2012-01-04	15,000	$0.67	$10.1K	21,000	SEC↗
MCNALLY ROBERT T	President/CEO	P Buy	2011-12-30	2012-01-04	29,850	$0.67	$20.0K	29,850	SEC↗
ROBINSON HARRIET L	Chief Scientific Officer	P Buy	2011-12-30	2012-01-04	149,254	$0.67	$100.0K	1,201,226	SEC↗
DODD DAVID A	Director	P Buy	2011-12-30	2012-01-04	112,000	$0.67	$75.0K	127,725	SEC↗
Kollintzas Dean G	Director	P Buy	2011-12-30	2012-01-04	14,925	$0.67	$10.0K	14,925	SEC↗
SPENCER JOHN N JR	Director	P Buy	2011-12-30	2012-01-04	14,925	$0.67	$10.0K	28,625	SEC↗